These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Redefining peripheral tolerance in the BALB/c to CBA mouse cardiac allograft model: vascular and cytokine analysis after transient CD4 T cell depletion. Mottram PL; Raisanen-Sokolowski A; Glysing-Jensen T; Stein-Oakley AN; Russell ME Transplantation; 1998 Dec; 66(11):1510-8. PubMed ID: 9869093 [TBL] [Abstract][Full Text] [Related]
24. Histopathology of cell mediated immune reaction in mouse colon--allograft rejection. Holden RJ; Ferguson A Gut; 1976 Sep; 17(9):661-70. PubMed ID: 976806 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of heme oxygenase-1 protects allogeneic thyroid grafts from rejection in naive mice. Niimi M; Takashina M; Takami H; Ikeda Y; Shatari T; Hamano K; Esato K; Matsumoto K; Kameyama K; Kodaira S; Wood KJ Surgery; 2000 Dec; 128(6):910-7. PubMed ID: 11114623 [TBL] [Abstract][Full Text] [Related]
26. Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts. Tourneur L; Malassagne B; Batteux F; Fabre M; Mistou S; Lallemand E; Lores P; Chiocchia G J Immunol; 2001 Aug; 167(3):1338-46. PubMed ID: 11466351 [TBL] [Abstract][Full Text] [Related]
27. Tolerance induction to cultured islet allografts. I. Characterization of the tolerant state. Coulombe M; Gill RG Transplantation; 1994 Apr; 57(8):1195-200. PubMed ID: 8178346 [TBL] [Abstract][Full Text] [Related]
28. Cross-reactivity of organs in allograft rejection. Comparison of effect of thyroid allografts on established islet allografts. Kover K; Hegre O; Popiela H; Biggs T; Moore WV Diabetes; 1987 Nov; 36(11):1268-70. PubMed ID: 3117605 [TBL] [Abstract][Full Text] [Related]
29. Rejection of cultured thyroid allografts by the transfer of sensitized LYT 2+ T cells. Warren HS; Pembrey RG Transplantation; 1986 Apr; 41(4):421-6. PubMed ID: 3083539 [TBL] [Abstract][Full Text] [Related]
30. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394 [TBL] [Abstract][Full Text] [Related]
31. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice. Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332 [TBL] [Abstract][Full Text] [Related]
32. Long-term limb allograft survival using anti-CD40L antibody in a murine model. Tung TH; Mackinnon SE; Mohanakumar T Transplantation; 2003 Mar; 75(5):644-50. PubMed ID: 12640303 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082 [TBL] [Abstract][Full Text] [Related]
34. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800 [TBL] [Abstract][Full Text] [Related]
35. Influence of histocompatibility and transplant site on survival. Perloff LJ; Utiger RD; Alavi A; Barker CF Ann Surg; 1978 Aug; 188(2):186-96. PubMed ID: 686886 [TBL] [Abstract][Full Text] [Related]
36. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Wong W; Morris PJ; Wood KJ Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815 [TBL] [Abstract][Full Text] [Related]
37. Prolongation of survival of fully allogeneic cardiac grafts and generation of regulatory cells by a histamine receptor 2 antagonist. Inoue F; Zhang Q; Akiyoshi T; Aramaki O; Iwami D; Matsumoto K; Kitagawa Y; Shirasugi N; Niimi M Transplantation; 2007 Nov; 84(10):1288-97. PubMed ID: 18049114 [TBL] [Abstract][Full Text] [Related]
38. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft. Wong W; Morris PJ; Wood KJ Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273 [TBL] [Abstract][Full Text] [Related]